Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Finance
Eli Lilly slashes insulin prices, starting a race to the bottom
Eli Lilly said it will slash the list price for some of its insulin products, raising questions about what will happen to other insulin cost efforts.
Bram Sable-Smith, Kaiser Health News
,
Samantha Young, Kaiser Health News
Mar 3, 2023 12:22pm
California sues major PBMs, drugmakers over insulin prices
Jan 13, 2023 3:15pm
Shifting coverage for COVID-19 treatments a challenge: experts
Oct 19, 2022 5:05pm
Merck sues HHS to avoid fine over 340B restrictions
Jul 12, 2022 3:20pm
24 states support feds in 340B drugmaker lawsuit
May 17, 2022 7:50am
Anthem, big pharma develop toolkit on digital clinical measures
Apr 4, 2022 11:21am